Goolaerts A, Pellan-Randrianarison N, Larghero J, Vanneaux V, Uzunhan Y, Gille T, Dard N, Planès C, Matthay MA, Clerici C. Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury. Am J Physiol Lung Cell Mol Physiol. 2014;306(11):L975-85. [IF=4.28]

Gille T, Randrianarison-Pellan N, Goolaerts A, Dard N, Uzunhan Y, Ferrary E, Hummler E, Clerici C, Planès C. Hypoxia-induced inhibition of epithelial Na(+) channels in the lung. Role of Nedd4-2 and the ubiquitin-proteasome pathway. Am J Respir Cell Mol Biol. 2014;50(3):526-37. [IF=4.10]

Kambouchner M, Levy P, Nicholson AG, Schubel K, Magois E, Feuillet S, Valeyre D, Bernaudin JF, Nunes H. Prognostic relevance of histological variants in nonspecific interstitial pneumonia. Histopathology. 2014;65(4):549-60. [IF=3.52]

Canouï-Poitrine F, Veerabudun K, Larmignat P, Letournel M, Bastuji-Garin S, Richalet JP. Risk prediction score for severe high altitude illness: a cohort study. PLoS One. 2014;9(7):e100642. [IF=2.81]

Espinoza JR, Alvarez G, León-Velarde F, Preciado HF, Macarlupu JL, Rivera-Ch M, Rodriguez J, Favier J, Gimenez-Roqueplo AP, Richalet JP. Vascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean population. High Alt Med Biol. 2014;15(2):146-54. [IF=1.71]

Voituron N, Jeton F, Cholley Y, Hasnaoui-Saadani RE, Marchant D, Quidu P, Favret F, Richalet JP, Pichon A. Catalyzing role of erythropoietin on the nitric oxide central pathway during the ventilatory responses to hypoxia. Physiol Rep. 2014 14;2(2):e00223.

Chaillou T, Koulmann N, Meunier A, Chapot R, Serrurier B, Beaudry M, Bigard X. Effect of hypoxia exposure on the recovery of skeletal muscle phenotype during regeneration.Mol Cell Biochem. 2014;390(1-2):31-40. [IF=2.67]

Chaillou T, Koulmann N, Meunier A, Pugnière P, McCarthy JJ, Beaudry M, Bigard X. Ambient hypoxia enhances the loss of muscle mass after extensive injury. Pflugers Arch. 2014;466(3):587-98. [IF=3.16]

Charlot K, Cornolo J, Borne R, Brugniaux JV, Richalet JP, Chapelot D, Pichon A. Improvement of energy expenditure prediction from heart rate during running. Physiol Meas. 2014;35(2):253-66.

Hidalgo M, Marchant D, Quidu P, Youcef-Ali K, Richalet JP, Beaudry M, Besse S, Launay T. Oxygen modulates the glutathione peroxidase activity during the L6 myoblast early differentiation process. Cell Physiol Biochem. 2014;33(1):67-77. [IF=2.67]

Pichon A, Lamarre Y, Voituron N, Marchant D, Vilar J, Richalet JP, Connes P. Red blood cell deformability is very slightly decreased in erythropoietin deficient mice. Clin Hemorheol Microcirc. 2014;56(1):41-6. [IF=1.68]

Valeyre D. An algorithm to predict survival in pulmonary sarcoidosis. Lancet Respir Med. 2014;2(2):87-8. [IF=19.29]

Naccache JM, Bouvry D, Valeyre D. Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID. Eur Respir J. 2014;43(3):924-5. [IF=10.57]

Nunes H, Monnet I, Kannengiesser C, Uzunhan Y, Valeyre D, Kambouchner M, Naccache JM. Is telomeropathy the explanation for combined pulmonary fibrosis and emphysema syndrome?: report of a family with TERT mutation. Am J Respir Crit Care Med. 2014;189(6):753-4. [IF=13.20]

Valeyre D, Albera C, Bradford WZ, Costabel U, King TE Jr, Leff JA, Noble PW, Sahn SA, du Bois RM. Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis. Respirology. 2014 Jul;19(5):740-7. [IF=3.08]

Woorons X, Gamelin FX, Lamberto C, Pichon A, Richalet JP. Swimmers can train in hypoxia at sea level through voluntary hypoventilation. Respir Physiol Neurobiol. 2014;190:33-9. [IF=1.66]

Gaillot-Drevon M, Calender A, Blay JY, Valeyre D, Israel-Biet D, Roy P, Pacheco Y. Lack of correlation of BTNL2 polymorphism and cancer risk in sarcoidosis. BTNL2 and cancer risk in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(2):136-41. [IF=1.58]

Aouizerate J, De Antonio M, Bassez G, Gherardi RK, Berenbaum F, Guillevin L, Berezne A, Valeyre D, Maisonobe T, Dubourg O, Cosnes A, Benveniste O, Authier FJ. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol Commun. 2014 Oct 23;2:154.

Bohelay G, Bouaziz JD, Nunes H, Rybojad M, Bagot M, Petit A, Laroche L. Striking leflunomide efficacy against refractory cutaneous sarcoidosis. J Am Acad Dermatol. 2014;70(5):e111-3. [IF=7]

Comarmond C, Crestani B, Tazi A, Hervier B, Adam-Marchand S, Nunes H, Cohen-Aubart F, Wislez M, Cadranel J, Housset B, Lloret-Linares C, Sève P, Pagnoux C, Abad S, Camuset J, Bienvenu B, Duruisseaux M, Hachulla E, Arlet JB, Hamidou M, Mahr A, Resche-Rigon M, Brun AL, Grenier P, Cacoub P, Saadoun D. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore). 2014;93(24):340-9. [IF=5.72]

Droitcourt C, Rybojad M, Porcher R, Juillard C, Cosnes A, Joly P, Lacour JP, D'Incan M, Dupin N, Sassolas B, Misery L, Chevrant-Breton J, Lebrun-Vignes B, Desseaux K, Valeyre D, Revuz J, Tazi A, Chosidow O, Dupuy A. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis. Chest. 2014 Oct;146(4):1046-54. [IF=6.04]

du Bois RM, Albera C, Bradford WZ, Costabel U, Leff JA, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014 May;43(5):1421-9. [IF=10.57]

Gaudry S, Vincent F, Rabbat A, Nunes H, Crestani B, Naccache JM, Wolff M, Thabut G, Valeyre D, Cohen Y, Mal H. Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. J Thorac Cardiovasc Surg. 2014 Jan;147(1):47-53. [IF=4.45]

Jamilloux Y, Néel A, Lecouffe-Desprets M, Fèvre A, Kerever S, Guillon B, Bouvry D, Varron L, Redares C, Dominique S, Roux M, Chapelon-Abric C, Valeyre D, Ducray F, Bernard C, Broussolle C, Hamidou M, Sève P. Progressive multifocal leukoencephalopathy in patients with sarcoidosis. Neurology. 2014;82(15):1307-13. [IF=7.59]

Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A. Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area. Arthritis Care Res (Hoboken). 2014;66(3):454-63. [IF=3.32]

Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29;370(22):2071-82. [IF=59.56]

Saidenberg-Kermanac'h N, Semerano L, Nunes H, Sadoun D, Guillot X, Boubaya M, Naggara N, Valeyre D, Boissier MC. Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients. Arthritis Res Ther. 2014 Mar 24;16(2):R78. [IF=4.12]

Duchemann B, Lavolé A, Naccache JM, Nunes H, Benzakin S, Lefevre M, Kambouchner M, Périé S, Valeyre D, Cadranel J. Laryngeal sarcoidosis: a case-control study. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):227-34. [IF=1.58]

Costabel U, Albera C, Bradford WZ, Hormel P, King TE Jr, Noble PW, Sahn SA, Valeyre D, du Bois RM. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):198-205. [IF=1.58]

Moraga FA, Jiménez D, Richalet JP, Vargas M, Osorio J. Periodic breathing and oxygen supplementation in Chilean miners at high altitude (4200m). Respir Physiol Neurobiol. 2014;203:109-15. [IF=1.66]